AstraZenica (AZN) chooses Charles River (CRL) as its partner for in vivo biology, which will...

|By:, SA News Editor

AstraZenica (AZN) chooses Charles River (CRL) as its partner for in vivo biology, which will allow AZN to create a "flexible research platform." The deal is for three years and is expected to contribute approximately 1% to Charles Rivers' total net sales in 2013. (PR)